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Purpose: To investigate whether the GLC3A locus harboring the CYP1B1 gene is associated 
with normal tension glaucoma (NTG) in Japanese patients.
Materials and Methods: One hundred forty-two Japanese patients with NTG and 101 
Japanese healthy controls were recruited. Patients exhibiting a comparatively early onset were 
selected as this suggests that genetic factors may show stronger involvement. Genotyping and 
assessment of allelic diversity was performed on 13 highly polymorphic microsatellite markers 
in and around the GLC3A locus.
Results: There were decreased frequencies of the 444 allele of D2S0416i and the 258 allele of 
D2S0425i in cases compared to controls (P = 0.022 and P = 0.034, respectively). However, this 
statistical signiﬁ  cance disappeared when corrected (Pc   0.05). We did not ﬁ  nd any signiﬁ  cant 
association between the remaining 11 microsatellite markers, including D2S177, which may 
be associated with CYP1B1, and NTG (P   0.05).
Conclusions: Our study showed no association between the GLCA3 locus and NTG, suggest-
ing that the CYP1B1 gene, which is reportedly involved in a range of glaucoma phenotypes, 
may not be an associated factor in the pathogenesis of NTG.
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Introduction
Glaucoma is a progressive optic neuropathy leading to permanent visual loss that is 
often associated with elevated intraocular pressure (IOP). Primary open-angle glaucoma 
(POAG) is the most common type of glaucoma. Normal tension glaucoma (NTG) is 
an important subset of POAG; while many POAG patients have high IOP,1 patients 
with NTG have statistically normal IOP.2–4 The prevalence of NTG is higher among the 
Japanese population than among Caucasians, and recent studies reported that 92% of 
POAG patients in Japan had NTG.5–8 The diagnosis of glaucoma is based on a combina-
tion of factors including optic nerve damage and speciﬁ  c ﬁ  eld defects for which IOP 
is the only treatable risk factor. NTG, however, tends to be underdiagnosed because of 
an accompanying high myopia in many cases and the lack of elevated IOP. Although 
relatively higher IOP, myopia, and older age are known to be factors associated with 
the development of NTG,9 they are not pathognomonic and there remains a growing 
interest in the identiﬁ  cation of pathogenetic factors associated with NTG.
Glaucoma is genetically heterogeneous and the detection of susceptibility genes could 
provide useful information for early diagnosis of glaucoma. To date, over 30 genetic loci 
for glaucoma have been identiﬁ  ed by linkage analysis in multiple pedigrees; 10–12 14 loci of 
POAG, 3 loci of primary congenital glaucoma (PCG), and 1 locus of pigment dispersion 
syndrome have been designated GLC1A-GLC1N, GLC3A-GLC3C, and GPDS1 (with 
approval from the HUGO Genome Nomenclature Committee), respectively. Among them, 
GLC3A harbors cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1).13 
CYP1B1 sapans 8.5 kb on chromosome 2p21 with three exons, and mutation of this gene 
is a major cause of PCG.10,13 Most CYP1B1 mutations are genetic insertions, deletions, Clinical Ophthalmology 2009:3 184
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or missense mutations, indicating that CYP1B1 is relatively 
susceptible to recombination events.10 CYP1B1 has also been 
found to be involved in the development of juvenile-onset glau-
coma (juvenile open angle glaucoma [JOAG]).14–16 In addition, 
recent studies have shown that CYP1B1 mutations are related 
to POAG in several ethnic groups,10 and there have been reports 
of delayed expression of a CYP1B1 mutation and coexistence 
of PCG and POAG in the same pedigree.17,18 These recent stud-
ies suggest that CYP1B1 mutations in the GLC3A locus may 
contribute to a broader range of glaucoma phenotypes than the 
PCG phenotype alone, including NTG.
In this study, with prospective SNP analysis of the CYP1B1 
gene in NTG patients in mind, we performed comprehensive 
microsatellite mapping in and around the GLC3A locus and 
investigated the disease-susceptibility of this locus in NTG 
patients.
Materials and methods
Subjects
We recruited 243 Japanese subjects from the Yokohama City 
University, Yamanashi University, Gifu University, Kobe 
University, Yamaguchi University, Kumamoto University, 
Hokkaido University, Tokyo University, Niigata University, 
Kanazawa University, Hiroshima University, Tajimi Municipal 
Hospital, and Tokai University in Japan. Of these subjects, 
142 were diagnosed with NTG, and 101 were control subjects. 
The control subjects were of the same age and sex as the NTG 
patients, and they were not affected by glaucoma or any oph-
thalmological or systemic diseases that could result in optic 
nerve or visual ﬁ  eld changes. Furthermore, the control cases 
either had no myopia or had mild myopia with refractive errors 
of −3.00 D or less. All patients and control subjects were of 
Japanese ethnicity, with similar social backgrounds and residing 
in the same urban area. Informed consent was obtained from all 
patients, and the study was conducted in accordance with the 
Declaration of Helsinki and subsequent revisions thereof.
NTG patients enrolled in this study were diagnosed as 
such if the patient had the following conditions: glaucomatous 
changes in the optic nerve head with or without retinal nerve 
ﬁ  ber layer defect and corresponding glaucomatous visual ﬁ  eld 
defects; normal open angle with angle width greater than Shaffer 
grade 2; absence of intraocular pressure greater than 21 mmHg 
on repeated examination by Goldmann applanation tonometry 
without medication; neurologic, rhinologic, and general 
medical examinations including magnetic resonance imaging 
that failed to disclose any pathology responsible for optic nerve 
change. Glaucomatous optic nerve abnormality was diagnosed 
when the vertical cup/disc ratio of the optic nerve head was 
more than or equal to 0.7, or the rim width at the superior portion 
(11–1 hour) or inferior portion (5–7 hour) was less than or equal 
to 0.1 of disc diameter, or the difference of the vertical cup/disc 
ratio was greater than or equal to 0.2 between both eyes, or a 
nerve ﬁ  ber layer defect was found. Glaucomatous visual ﬁ  eld 
defect was deﬁ  ned on a hemiﬁ  eld basis using a reliable ﬁ  eld 
data examined by the Humphrey® static visual ﬁ  eld analyser 
(Carl Zeiss Meditec, Oberkochen, Germany,) C-30-2 program 
according to the Anderson and Patella’s criteria; 19 the hemiﬁ  eld 
was judged abnormal when the pattern deviation probability 
plot showed a cluster of three or more nonedge-contiguous 
points having sensitivity with a probability of less than 5% in 
the upper or lower hemiﬁ  eld, and in one of these with a prob-
ability of less than 1%.
The following inclusion and exclusion criteria were used 
to stringently categorize the patient groups in this study. We 
excluded individuals who were diagnosed under 20 or over 
60 years of age and who had –8.0 D or higher myopic refrac-
tive error of spherical equivalence. The selection criteria of 
HFA mean deviation were stratiﬁ  ed depending on the sub-
jects’ age in order to minimize the effect of aging on retinal 
ganglion cell loss and subsequent visual ﬁ  eld defect(s) (i) no 
limitation if the patient was diagnosed under 50 years of age 
(ii) −10.00 dB or worse in at least one eye if the patient was 
diagnosed between 50 and 55 years of age (iii) −15.00 dB 
or worse in at least one eye if the patient was diagnosed 
above 55 years of age. In this study, the cases exhibiting a 
comparatively early onset were selected as they suggest that 
genetic factors may show stronger involvement.
During diagnosis, patients whose refraction values had 
changed due to cataract surgery, refractive surgery, or other 
intervention were excluded from the study. In cases where 
a glaucomatous visual ﬁ  eld defect was present only in one 
eye, the refraction value and glaucomatous visual ﬁ  eld defect 
of the affected eye were adopted. In cases where a glaucoma-
tous visual ﬁ  eld defect was present in both eyes, the refrac-
tion value and glaucomatous visual ﬁ  eld defect of the more 
severely affected eye were adopted.
Analysis of repeat polymorphisms 
for 13 microsatellite markers
Genomic DNA was extracted using the QIAamp DNA Blood 
Mini Kit (QIAGEN, Hilden, Germany) or the guanidine 
method. In this association study, we selected 13 highly 
polymorphic microsatellite markers that are located in and 
around the GLC3A locus as shown in Figure 1. The markers 
were determined based on the National Center for Biotech-
nology Information for ﬁ  ne mapping. Polymerase chain Clinical Ophthalmology 2009:3 185
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reaction (PCR) was performed in a reaction mixture with 
a total volume of 12.5 μl containing PCR buffer, genomic 
DNA, 0.2 mM dinucleotide triphosphates (dNTPs), 0.5 μM 
primers, and 0.35 U Taq polymerase. The PCR conditions 
were as follows: 94 °C for 5 min, followed by 30 cycles of 
denaturation at 94 °C for 30 sec, annealing at 56 °C for 30 sec, 
extension at 72 °C for 1 min, and a ﬁ  nal elongation step at 
72 °C for 10 min. The reaction was carried out in a PCR 
thermal cycler (GeneAmp System 9700, Applied Biosystems, 
Foster City, CA, USA). The forward primer was labelled at 
the 5´ end with 6-FAM, VIC, PET, or NED (Sigma-Aldrich, 
St. Louis, MO, USA) (Table 1). To determine the number of 
microsatellite repeats, the PCR products were denatured at 
97 °C for 2 min, mixed with formamide, and electrophoresed 
using an ABI3130 Genetic Analyser (Applied Biosystems). 
The number of microsatellite repeats was estimated automati-
cally using the GeneScan 672 software (Applied Biosystems) 
by the local Southern method with a size marker of GS500 
TAMRA (Applied Biosystems).
Statistical analysis
Allelic frequencies were estimated by direct counting. The 
signiﬁ  cance of allelic frequencies between the patient and 
control groups was evaluated by Fisher’s exact test. The 
probability of association was corrected by the Bonferroni 
inequality method, ie, by multiplying the obtained P values 
with the number of alleles compared. A corrected P (Pc) 
value of  0.05 was considered statistically signiﬁ  cant. 
Statistical analyses were performed on a computer using the 
SPSS software (version 10.1; SPSS Inc., Chicago, IL, USA). 
Haplotype frequencies and linkage disequilibrium (LD) in 
the multi-locus analyses were calculated using PyPop.20 
Haplotype frequencies were estimated using the iterative 
Expectation-Maximization algorithm. LD was measured 
using Hedrick’s multiallelic D’ statistic.21
Results
Patient age range was 21–58 years (mean 49.1 ± 9.7); 47.2% 
were male and 52.8% were female. The mean refraction value 
was −3.74 ± 3.02 diopters (D), and the mean deviation observed 
in the Humphrey® static visual ﬁ  eld determination (Carl Zeiss 
Meditec, Oberkochen, Germany) was −10.14 ± 8.04 dB.
We genotyped 13 polymorphic microsatellite markers in 
and around the GLC3A locus in 142 patients and 101 controls 
(Figure 1). The observed and expected frequencies of each 
genotype for the 13 markers in the case and control subjects 
were in Hardy–Weinberg equilibrium (data not shown). 
Only two adjacent markers, D2S0416i and D2S0425i, were 
signiﬁ  cantly positive, as shown in Table 2, and the frequency 
of the 444 allele of D2S0416i and the 258 allele of D2S0425i 
were decreased in cases compared to controls (P = 0.022, 
OR = 0.59 and P = 0.034, OR = 0.42, respectively). How-
ever, this statistical signiﬁ  cance disappeared (Pc   0.05) 
when evaluated by Bonferroni correction. The magnitude 
of LD between these two markers was low, with pair-wise 
D’ = 0.25, and the comparison of haplotype consisting of 
two alleles (D2S0416i_444 and D2S0425i_258) rendered no 
signiﬁ  cant difference between cases and controls (cases vs 
controls = 3.5% vs 7.3%, P = 0.055) (data not shown).
Discussion
The purpose of this study was to investigate whether the 
GLC3A locus is associated with NTG in Japanese subjects, 
based on results from recent studies reporting that the 
CYP1B1 gene, located at the GLC3A locus on chromo-
some 2p21, could be a causative gene in POAG as well as 
PCG. To this end, we genotyped 13 microsatellite markers 
in and around the GLC3A locus. Here we report a lack of 
association between the GLC3A locus and NTG in Japanese 
patients, suggesting that genetic variation at this locus may 
not play an important role in the development of NTG.
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Figure 1 Location of 13 microsatellite markers used in this study.   The heavy bar above the chromosome represents the 2p22.1-p22.3 region including the GLC3A locus.Clinical Ophthalmology 2009:3 186
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Sarfarazi and colleagues mapped GLC3A as a putative 
PCG locus to 2p21 in 11 Turkish families, and the D2S177 
microsatellite, located 270 kb telomeric to the CYP1B1 
gene, showed a maximal LOD score of 9.40.22 Bejjani and 
colleagues also reported that the maximal LOD score was 
15.76 with D2S177 in 25 Saudi Arabian PCG families.23 
Recently, it has been reported that the D2S177 allele was 
associated with CYP1B1 mutations related to PCG.24 
Therefore, D2S177 may be potentially useful as a marker 
for genetic events associated with glaucoma, such as 
CYP1B1 mutations. In the present study, we did not ﬁ  nd 
any signiﬁ  cant association between D2S177 alleles and 
NTG, suggesting that CYP1B1 mutations may not be a risk 
factor for NTG. It has been hypothesized that mutations of 
CYP1B1 cause developmental abnormality in the structure 
and function of the anterior ocular segment.25 However, NTG 
patients have statistically normal IOP with no abnormality 
in the structure of anterior ocular segment, suggesting that 
CYP1B1 is a potential disease susceptibility gene of PCG, 
POAG, and JOAG, but not NTG. On the other hand, we 
found a weak association between two adjacent markers, 
D2S0416i and D2S0425i, and NTG, although this link did 
not reach statistical signiﬁ  cance when corrected. These two 
markers were located ∼860 kb centromeric to the CYP1B1 
gene. The nearest gene of D2S0416i is the SOS1 (son of sev-
enless homolog 1 [Drosophila]) gene, which is about 40 kb 
from the marker. SOS1 encodes a protein that is a guanine 
nucleotide exchange factor for RAS proteins,26 and muta-
tions in this gene are associated with gingival ﬁ  bromatosis 
and Noonan syndrome.27–29 Another marker, D2S0425i, is 
within the CDKL4 (cyclin-dependent kinase-like 4) gene, 
a member of the Ser/Thr protein kinase family. Currently, 
there are no reports suggesting any connection between these 
two genes and NTG.
Previous studies reported that mutations in genes such as 
optic atrophy 1 (OPA1),30–32 apolipoprotein E (APOE),33,34 
and optineurin (OPTN)35–37 are implicated in NTG. Recently, 
WD repeat-domain 36 (WDR36),38 endothelin receptor 
Table 1 Primer sequences of 13 microsatellite markers used in this study
Locus Dye label Primer sequences (5'-to-3') Allele size range
D2S2230 VIC F CTTAGAAACGAACCACTGGA 224–232
R GTGGAAATAAGTGCAACCAT
D2S1895i VIC F AAGGATAACCACTCTATCTGCTAC 285–295
R GAGCTCTGATTCTATGTATCAAAG
D2S0367i 6-FAM F CTATCAATTCCTGCATCTAACTAT 297–335
R TAGTTACTGGATGGCTGTGTAC
D2S1501i PET F AGTCAATCTGGACTGCTGG 124–142
R AGCCCTCAGTACGCAGTAG
D2S1243i NED F TCCTCAGATTCACTAAACTCATAC 284–298
R TGTCAAGTGATGTTAAGTGCTA
D2S177 PET F AGCTCAGAGACACCTCTCCA 287–311
R CTGTATTAGGATACTTGGCTATTGA
D2S0973i 6-FAM F AGTTGTAAAGTATCAAGCCATAAA 243–269
R GCAGAATGGAACTTAGTGTCTA
D2S2331 NED F ATTAGCACTTACCTGGCACA 126–140
R AGTTTATGCTGTGATTAATACCTGG
D2S0416i 6-FAM F CACTCAGTGGCCATTAGAG 440–454
R GTAGATTCAGAATTTATGAACCAC
D2S0425i PET F CTTAAGTACCTTCATGAAGTTCAG 254–260
R CAGGAGTTCAAGGTTAAAGTAAG
D2S0161i NED F GTCTAAGTCAGTAGCATAGCCAAG 292–322
R ACGGCTTGAAGTTATAGGAGAC
D2S0099i PET F GCTAACTTTAACTGATTAAGCAAA 351–363
R CATTACCAGTGAGCCTCAC
D2S1903i NED F TTACCAGTATGCCACTAAACTTAC 242–268
R CAGCTTTCTTAATACAGCAAAGClinical Ophthalmology 2009:3 187
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type A (EDNRA)39,40 methylenetetrahydrofolate reductase 
(MTHFR),41 and β-1-adrenergic receptor (ADRB1)42 have also 
been reported as risk factors for NTG. However, associations 
between these genes and NTG were not strong or not often 
replicated in other populations,43–47 suggesting that there may 
be other unknown genetic factors having more powerful effects 
on the development of NTG than those identiﬁ  ed so far.
In conclusion, we performed an association analysis of the 
GLC3A locus including the CYP1B1 gene using microsatel-
lite markers in NTG patients, but the marker involved in NTG 
was not detected in this locus. In NTG patients, diagnosis 
is usually made after a visual ﬁ  eld defect has occurred, due 
to few subjective symptoms and normal IOP. Therefore it is 
necessary to identify a disease susceptibility gene and elu-
cidate pathogenic mechanisms of NTG for early diagnosis, 
prevention, and therapeutic development.
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